# ClinicalTrials.gov record NCT03574597

> PeptideScanner retained ClinicalTrials.gov record NCT03574597 at 2026-07-30T18:41:37.951Z. Its registry update date was 2024-08-30, and PeptideScanner's reviewed identity mapping was semaglutide.

- Evidence object: `story:clinicaltrials-gov-nct03574597-semaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-08-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03574597-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03574597-semaglutide-v1.json
- Content SHA-256: `bec6f43c6b331c27f8b4a02616eabcc8a40f941bda42164cb6214eaa3be2753a`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03574597 ([`ctg-observation-nct03574597-2024-08-30-ea4738ed0d35`](#source-ctg-observation-nct03574597-2024-08-30-ea4738ed0d35))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03574597 at 2026-07-30T18:41:37.951Z. Its registry update date was 2024-08-30, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct03574597-2024-08-30-ea4738ed0d35`](#source-ctg-observation-nct03574597-2024-08-30-ea4738ed0d35))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03574597 at 2026-07-30T18:41:37.951Z. Its registry update date was 2024-08-30, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct03574597-2024-08-30-ea4738ed0d35`](#source-ctg-observation-nct03574597-2024-08-30-ea4738ed0d35))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03574597-2024-08-30-ea4738ed0d35`](#source-ctg-observation-nct03574597-2024-08-30-ea4738ed0d35))

## Sources

<a id="source-ctg-observation-nct03574597-2024-08-30-ea4738ed0d35"></a>
- **ClinicalTrials.gov record NCT03574597 · retained source version 2024-08-30:ea4738ed0d355d47769d8430d76fc9b77fff7831394c1ab9a761cde3164b96b2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03574597) (`ctg-observation-nct03574597-2024-08-30-ea4738ed0d35`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03574597." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03574597-semaglutide-v1.json SHA-256: bec6f43c6b331c27f8b4a02616eabcc8a40f941bda42164cb6214eaa3be2753a.